Ravenquest BioMed (CSE: RQB) (OTC: Coming Soon) - Investor Dashboard

RavenQuest BioMed
CSE Symbol: RQB
OTC Ticker: N/A
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: N/A
Established: 2015
CEO: George Robinson

RavenQuest BioMed – Cannabis Operations

Services Division

The RavenQuest Services Division delivers comprehensive, integrated solutions to companies in the cannabis industry. This division has a seven-year history with multiple revenue streams from both one-time and recurring sources. The turnkey, end-to-end offering provides growing and drying technologies, patient and genetic management systems, and security management solutions.

The team has helped many Licensed Producer (LP) clients reach cultivation and/or sell/dispense licensing. RQB boasts a 100% success rate in navigating clients through the complex late-stage application phase which moves from pre-license inspection letter, facility construction and ultimately to full license status.

  • Consulting – comprehensive cannabis consulting services
  • Solutions – implementation, project management, ongoing support
  • Training solutions – training of operators, engineers, architects and installers
  • Design studio – demonstration and training facility

ACMPR Investments

The Investment / Acquisition Division will focus on equity investments in select ACMPR applicants or LPs. AGB will be the acquisition.

AGB is a private, Edmonton-based company that has made an application for an LP license under the ACMPR. AGB has received its pre-license inspection letter from Health Canada. As such, once the facility is constructed according to the submitted plans it can be inspected by Health Canada. The application and facility design was completed by the Services Group, which has a 100% success rate in moving applicants from pre-license inspection through to approval. AGB has a lease with an option to purchase on a 35,500 square-foot facility in Edmonton, Alberta. Approximately $14 million to $16 million is required to complete the facility, at which point the expected capacity is 7,000 kilograms (“kgs”) of cannabis per annum.

With propriety growing technology and systems designed by the Services Division, AGB is expected to have one of the highest yields per square foot in the industry. The facility has been designed to be a low-cost, high volume producer of quality cannabis.

Visit RavenQuest BioMed, Inc.,
at www.rqbglobal.com

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. RavenQuest BioMed, Inc., is a client of NCV Media, LLC. Read our full disclaimer.